Search results

6 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
DeSimone talks about research, developing new medicines
Located in News / 2012 News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
UNC study shows potential for nanotechnology-based therapy for ovarian cancer
Chapel Hill - A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.
Located in News / 2011 News
Wang published in ACS Nano
UNC Lineberger member Andrew Wang, MD, was senior author of a preclinical study published in the journal ACS Nano. Wang and collaborators found that they could improve cancer chemotherapy and chemoradiotherapy treatments by delivering a combination of cancer-fighting drugs using nanoparticles.
Located in Newsletters / / Honors and Awards / 2015
Located in Newsroom / UNC Lineberger in the News